GoodRx Holdings, Inc. 8-K

What Happened
GoodRx Holdings, Inc. announced on April 23, 2026 that its Board appointed Thomas Chan, previously Vice President, Corporate Controller, as the Company’s Chief Accounting Officer and principal accounting officer, effective immediately. Mr. Chan, 40, has been with GoodRx since October 2020 in various controllership and financial reporting roles and was previously an Audit & Assurance Senior Manager at Deloitte & Touche, LLP. He is a California Certified Public Accountant and holds a B.A. in Business Administration (accounting) from California State University, Fullerton.

Key Details

• Annual base salary increased to $310,000 and target annual bonus set at 40% of base salary.
• Equity awards to be granted under the 2020 Incentive Award Plan: an RSU award valued at $131,250 and a performance-based PSU award valued at $43,750.
• RSU vesting: ratably in 12 equal quarterly installments, first vesting on August 15, 2026, contingent on continued employment.
• PSU vesting: in three equal installments (one-third on March 3, 2027, then on the first and second anniversaries), subject to performance goals and continued employment. Awards’ share counts will be based on the closing price over the 30 calendar days before grant; expected grant on the first trading day of the first open window after the effective date.
• No related-party transactions required to be disclosed under Item 404(a) and no family relationships with current or former directors/executive officers. Mr. Chan signed the Company’s standard director/officer indemnification agreement.

Why It Matters
Naming a principal accounting officer is material to investors because that person is responsible for the company’s accounting policies, financial reporting and internal controls that underpin SEC filings and financial statements. This is an internal promotion from the controller ranks, signaling continuity in GoodRx’s finance leadership. The compensation package includes time- and performance-based equity, aligning part of Mr. Chan’s pay with future company performance and retention.